Mechanism of lncRNA-miRNA-related Signaling Pathways in Gastric Cancer and Chinese Medicine Intervention： A Review

LIANG Xinyi; MA Jiale; ZHAO Shuangmei; YANG Yan; LI Huizhen

doi:10.13422/j.cnki.syfjx.202201824

您当前的位置：

首页 >

文章列表页 >

Mechanism of lncRNA-miRNA-related Signaling Pathways in Gastric Cancer and Chinese Medicine Intervention： A Review

更新时间：2023-06-20

- Mechanism of lncRNA-miRNA-related Signaling Pathways in Gastric Cancer and Chinese Medicine Intervention： A Review
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 29, Issue 14, Pages: 256-264(2023)
- 作者机构：
  
  1.天津中医药大学，天津 301617
  2.天津中医药大学第二附属医院，天津 300250
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.202201824
  CLC： R22;R242;R2-031;R285.5
- Published：20 July 2023，
  
  Published Online：21 July 2022，
  
  Received：10 May 2022，
- 稿件说明：
扫描看全文
梁欣奕,马佳乐,赵双梅等.lncRNA-miRNA相关信号通路对胃癌的作用机制及中医药干预研究进展[J].中国实验方剂学杂志,2023,29(14):256-264.

LIANG Xinyi,MA Jiale,ZHAO Shuangmei,et al.Mechanism of lncRNA-miRNA-related Signaling Pathways in Gastric Cancer and Chinese Medicine Intervention： A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(14):256-264.
梁欣奕,马佳乐,赵双梅等.lncRNA-miRNA相关信号通路对胃癌的作用机制及中医药干预研究进展[J].中国实验方剂学杂志,2023,29(14):256-264. DOI： 10.13422/j.cnki.syfjx.202201824.

LIANG Xinyi,MA Jiale,ZHAO Shuangmei,et al.Mechanism of lncRNA-miRNA-related Signaling Pathways in Gastric Cancer and Chinese Medicine Intervention： A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(14):256-264. DOI： 10.13422/j.cnki.syfjx.202201824.

摘要

胃癌作为消化系统中最常见的恶性肿瘤之一，具有较高发病率和死亡率，早期临床症状不显著，大多发现后已进入进展期，大大降低了临床治愈率，严重影响患者生存质量，预后极差。近年来，随着生物信息分子领域的不断探索发现，微小核糖核酸（miRNA）和长链非编码RNA（lncRNA）作为不具备翻译能力的非编码RNA（ncRNA）而存在，并且通过作用于某一靶点，调节相关信号蛋白表达水平，从而激活或抑制某种信号通路，在胃癌进展过程中具有协助诊断、指导临床用药及判断预后的重要作用。中医药因临床疗效佳、药物不良反应少，投入临床使用易为患者所接受。着眼于当前阶段展开的一系列基础研究，以miRNA、lncRNA与信号通路之间相互作用机制作为切入点，借助中医药调控相关信号分子和信号通路的各项研究早已展开，并且经过大量实验研究数据现已证实，①胃癌的发生发展与miRNA、lncRNA及相关信号通路之间相互作用密不可分；②中医药凭借自身多靶点、多机制、多通路的优势，影响各类信号分子、信号通路，干预胃癌细胞进展。现对lncRNA、miRNA分子及主要信号通路参与胃癌发生发展过程，以及中医药调控各信号通路的具体分子机制的相关基础研究作一综述，以期结合中医药现代研究从分子水平对干预胃癌进展方面提供一定参考。

Abstract

Gastric cancer （GC） is one of the most common malignant tumors in the digestive system， with high morbidity and mortality. Early clinical symptoms of GC are not obvious， and most of them have entered the advanced stage after discovery， which greatly reduces the clinical cure rate and affects the quality of life of patients， and the prognosis is very poor. In recent years， with the continuous exploration in the field of bioinformatics， it has been found that micro-RNA （miRNA） and long non-coding RNA （lncRNA） exist as non-coding RNA （ncRNA） without translation ability， and regulate the expression levels of related signal proteins by acting on a certain target， thereby activating or inhibiting a certain signaling pathway， which plays an important role in assisting diagnosis， guiding clinical medication， and judging prognosis in the progress of GC. Chinese medicine is easily accepted by patients because of its good curative effect and less side effects. In the present basic studies， with the interaction mechanism between miRNA， lncRNA and signaling pathways as the breakthrough point， various studies on the regulation of related signaling molecules and signaling pathways by Chinese medicine have been carried out. A large number of experimental data have proved that the development of GC is closely related to the interaction of miRNA， lncRNA， and related signaling pathways， and Chinese medicine， with multi-target， multi-mechanism， and multi-pathway characteristics， affects various signaling molecules and signaling pathways and intervenes in the progress of GC cells. This paper reviewed the basic research on lncRNA， miRNA molecules， and main signaling pathways involved in the occurrence and development of GC， and summarized specific molecular mechanisms of Chinese medicine in the regulation of each signaling pathway， hoping to provide references for modern research of Chinese medicine in the intervention of GC progress at the molecular level.

关键词

微小核糖核酸（miRNA）长链非编码RNA（lncRNA）胃癌信号通路研究进展

Keywords

micro-RNA （miRNA）long non-coding RNA （lncRNA）gastric cancersignal pathwaysresearch progress

references

中国抗癌协会胃癌专业委员会.胃癌诊治难点中国专家共识（2020版）［J］.中国实用外科杂志，2020，40（8）：869-904.

左婷婷，郑荣寿，曾红梅，等.中国胃癌流行病学现状［J］.中国肿瘤临床，2017，44（1）：52-58.

MAO Y，LIU R，ZHOU H，et al.Transcriptome analysis of miRNA-lncRNA-mRNA interactions in the malignant transformation process of gastric cancer initiation［J］.Cancer Gene Ther，2017，24（6）：267-275.

CORREA P.Human gastric carcinogenesis： A multistep and multifactorial process-first American cancer society award lecture on cancer epidemiology and prevention［J］.Cancer Res，1992，52（24）：6735-6740.

MAGDALENA C，ANNA F A，ARNOLD O G J，et al.Distinct molecular subtypes of gastric cancer： From Laurén to molecular pathology［J］Oncotarget，2018，9（27）：19427-19442.

PATEL T N， ROY S， RAVI R， et al. Gastric cancer and related epigenetic alterations［J］.Ecancermedicalscience，2017， doi： 10.3332/ecancer.2017.714http://dx.doi.org/10.3332/ecancer.2017.714.

SEXTON R E，AL HALLAK M N ，DIAB M，et al.Gastric cancer： A comprehensive review of current and future treatment strategies［J］.Cancer Metastasis Rev，2020，39（4）：1179-1203.

沈钲杰，朱银银，沈凡含，等.lncRNA与miRNA调节关系和ceRNA关系在疾病中的研究进展［J］.中国细胞生物学学报，2018，40（10）：1774-1780.

LIU J，REN L，LI S，et al.The biology， function， and applications of exosomes in cancer［J］.Acta Pharm Sin B，2021，11（9）：2783-2797.

CLARK M B，JOHNSTON R L，INOSTROZA-PONTA M，et al.Genome-wide analysis of long noncoding RNA stability［J］.Genome Res，2012，22（5）：885-898.

TANG J，HUANG F，WANG H，et al.Knockdown of TPT1-AS1 inhibits cell proliferation， cell cycle G1/S transition，and epithelial-mesenchymal transition in gastric cancer［J］.Bosn J Basic Med Sci，2021，21（1）：39-46.

JIAO J，ZHANG S. Long non‑coding RNA MEG‑3 suppresses gastric carcinoma cell growth， invasion and migration via EMT regulation［J］.Mol Med Rep，2019，20（3）：2685-2693.

WEI G H，WANG X.lncRNA MEG3 inhibit proliferation and metastasis of gastric cancer via p53 signaling pathway［J］.Eur Rev Med Pharmacol Sci，2017，21（17）：3850-3856.

WANG B，DENG Y，JIN J，et al.Long noncoding RNA LIT3527 knockdown induces apoptosis and autophagy through inhibiting mTOR pathway in gastric cancer cells［J］.J Cancer，2021，12（16）：4901-4911.

ZHAO J，DU P，CUI P，et al.LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer［J］.Oncogene，2018，37（30）：4094-4109.

刘辉，张超，景丽伟，等.基于WGCNA联合LASSO算法胃癌预后lncRNA 分子标志物筛选［J］.临床肿瘤学杂志，2021，26（10）：891-897.

ZHANG X，WU J.LINC00665 promotes cell proliferation， invasion，and metastasis by activating the TGF-β pathway in gastric cancer［J］.Pathol Res Pract，2021， doi：10.1016/j.prp.2021.153492http://dx.doi.org/10.1016/j.prp.2021.153492.

HUI Y J，YANG Y，LI D P，et al.LncRNA FEZF1-AS1 Modulates cancer stem cell properties of human gastric cancer through miR-363-3p/HMGA2［J］.Cell Transplat，2020， doi：10.1177/0963689720925059http://dx.doi.org/10.1177/0963689720925059.

ZHANG W， LIAO K， LIU D.MiRNA-12129 suppresses cell proliferation and block cell cycle progression by targeting SIRT1 in gastric cancer［J］.Technol Cancer Res Treat，2020， doi：10.1177/1533033820928144http://dx.doi.org/10.1177/1533033820928144.

HUANGFU L T，HEQ F，HAN J，et al.MicroRNA-135b/CAMK2D axis contribute to malignant progression of gastric cancer through EMT process remodeling［J］.Int J Biol Sci，2021，17（8）：1940-1952.

YANG L Q，LI L N，CHAN P，et al.MiR-25 regulates gastric cancer cell growth and apoptosis by targeting EGR2［J］.Front Genet，2021， doi：10.3389/fgene.2021.690196http://dx.doi.org/10.3389/fgene.2021.690196.

XIE M，DART D A，GUO T，et al.MicroRNA-1 acts as a tumor suppressor microRNA by inhibiting angiogenesis-related growth factors in human gastric cancer［J］.Gastric Cancer，2018，21（1）：41-54.

YU Z L，RONG Z Y，SHENG J X，et al.Aberrant non-coding RNA expressed in gastric cancer and its diagnostic value［J］.Front Oncol，2021， doi：10.3389/fonc.2021.606764http://dx.doi.org/10.3389/fonc.2021.606764.

吴琼.MicroRNA-17-92促进胃癌干细胞自我更新及增殖的分子机制［D］.西安：第四军医大学，2013.

SUN L，LIU L，YANG J S，et al.SATB1 3'UTR and lncRNA UCA1 competitively bind to miR-495-3p and together regulate the proliferation and invasion of gastric cancer［J］.J Cell Biochem，2019，120（4）：6671-6682.

ZHANG Z，ZHU Z，WATABE K，et al.Negative regulation of lncRNA GAS5 by miR-21［J］.Cell Death Differ，2013，20（11）：1558-1568.

KENIRY A，OXLEY D，MONNIER P，et al.The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and IGF1r［J］.Nat Cell Biol，2012，14（7）：659-665.

LIU G，XIANG T，WU Q F，et al.Long Noncoding RNA H19-derived miR-675 enhances proliferation and invasion via RUNX1 in gastric cancer cells［J］.Oncol Res，2016，23（3）：99-107.

YU G，YAO W M，GUMIREDDY K，et al. Pseudogene PTENP1 functions as a competing endogenous RNA to suppress clear-cell renal cell carcinoma progression［J］.Mol Cancer Ther，2014，13（12）：3086-3097.

YAN J，GUO X Q，XIA J Z，et al.MiR-148a regulates MEG3 in gastric cancer by targeting DNA methyltransferase 1［J］.Med Oncol，2014，31（3）：879.

LIANG L C，LIU L Q，LIU L，et al.Long non-coding RNA BX357664 inhibits gastric cancer progression by sponging miR-183a-3p to regulate the PTEN expression and PI3K/Akt pathway［J］.Food Chem Toxicol，2021， doi：10.1016/j.fct.2021.112069http://dx.doi.org/10.1016/j.fct.2021.112069.

GUO L，MA H，KONG Y，et al.LncRNA TNK2-AS1/miR-125a-5p axis promotes tumor growth and modulated PI3K/AKT pathway［J］.J Gastroenterol Hepatol，2021，37（1）：124-133.

龚红霞，李婷婷，苏韫，等.归芪白术方含药血清通过PI3K/Akt信号通路对共培养的胃癌MKN-45细胞凋亡的影响［J］.时珍国医国药，2021，32（12）：2890-2893.

乔丹，张晟郡，王时玉，等.黄芩素介导FAK蛋白调控PI3K/Akt信号通路抑制胃癌HGC-27细胞增殖和迁移［J］.中国实验方剂学杂志，2022，28（7）：73-80.

WU Q，MA J L，WEI J，et al. LncRNA SNHG11 promotes gastric cancer progression by activating the Wnt/β-catenin pathway and oncogenic autophagy［J］.Mol Ther，2021，29（3）：1258-1278.

DENG S Q，ZHANG X J，QIN Y，et al.miRNA‐192 and ‐215 activate Wnt/β‐catenin signaling pathway in gastric cancer via APC［J］.J Cell Physiol，2020，235（9）：6218-6229.

谷金繁，王翔，陈建，等.加味小陷胸汤干预Wnt/β-catenin信号通路抑制人胃癌MGC803细胞上皮间质转化［J］.中国实验方剂学杂志，2022，28（4）：42-50.

刘萍，王伟，罗章梅.夏枯草提取物对MNNG诱导的大鼠胃癌组织Wnt/β-catenin信号通路的影响［J］.四川中医，2021，39（12）：52-55.

王阳，徐文广，董艳，等.lncRNA-Z38通过调控TGF-β通路促进胃癌的发生发展［J］.中国肿瘤生物治疗杂志，2021，28（12）：1174-1178.

MA Y，XUE H，WANG W F，et al.The miR-567/RPL15/TGF-β/Smad axis inhibits the stem-like properties and chemo-resistance of gastric cancer cells［J］.Transl Cancer Res，2020，9（5）：3539-3549.

WANG J，XU Z H，WANG Z，et al.TGF-beta signaling in cancer radiotherapy［J］.Cytokine，2021， doi：10.1016/j.cyto.2021.155709http://dx.doi.org/10.1016/j.cyto.2021.155709.

LIU J X，CHEN Y A，CAO Z Y，et al.Babao Dan inhibits the migration and invasion of gastric cancer cells by suppressing epithelial-mesenchymal transition through the TGF-β/Smad pathway［J］.J Int Med Res，2020，48（6）：300060520925598.

胡诚毅，莫志贤.黄连素的药理作用及机制研究进展［J］.中国实验方剂学杂志，2017，23（20）：213-219.

DU H Y，GU J Y，PENG Q，et al. Berberine suppresses EMT in liver and gastric carcinoma cells through combination with TGF-βR regulating TGF-β/Smad pathway［J］.Oxid Med Cell Longev，2021，doi：10.1155/2021/2337818http://dx.doi.org/10.1155/2021/2337818.

陶有茂.MicroRNA-216a通过抑制JAK2/STAT3信号通路抑制胃癌细胞侵袭转移及上皮间质转化［D］.吉林：吉林大学，2019.

XIAO C H，HONG H，YU H Z，et al.MiR-340 affects gastric cancer cell proliferation，cycle，and apoptosis through regulating SOCS3/JAK-STAT signaling pathway［J］. Immunopharmacol Immunotoxicol.2018，40（4）：278-283.

WANG X G，KAN J，HAN J，et al.LncRNA SNHG16 functions as an oncogene by sponging MiR-135a and promotes JAK2/STAT3 signal pathway in gastric cancer［J］.J Cancer，2019，10（4）：1013-1022.

ZHENG L，CHEN J，ZHOU Z，et al. Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway［J］.Tumour Biol，2017，39（5）：1010428317705335.

李毅，李文忠，师路，等.番泻苷B对胃癌细胞生长、凋亡、干样特性以及IL-6/JAK2/STAT3通路的影响［J］.免疫学杂志，2021，37（10）：861-867.

李磊，陈志武.姜黄素对胃癌细胞增殖、迁移及Hsp90/JAK/STAT3通路的影响［J］.安徽医科大学学报，2019，54（3）：448-451，457.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Regulation of Signaling Pathways Associated with Gastric Cancer by Chinese Medicine： A Review

Mechanism of Banxia Xiexintang in Prevention and Treatment of Gastric Cancer： A Review

Research Status of Traditional Chinese Medicine in Treating Gastric Cancer and Precancerous Lesion of Gastric Cancer by Regulating Autophagy

Zuoguiwan for Treating Congenital Essence Deficiency in Offspring

Traditional Chinese Medicine Treatment for Diabetes and Its Complications： A Review

Related Author

YANG Jingyun

XIE Jiacheng

MA Xiaocong

LUO Weisheng

ZHANG Yanmei

WEI Jingjing

ZHU Zhongbo

LIU Senyu

Related Institution

Graduate School， Guangxi University of Chinese Medicine

Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine

Gansu Engineering Laboratory for New Products of Traditional Chinese Medicine （TCM）， Gansu Key Laboratory of TCM Excavation and Innovative Transformation， Gansu University of Chinese Medicine

The First Clinical Collage， Hainan Medical University

College of TCM，Hainan Medical University

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰